Technology
Health
Pharmaceutical

Zynerba Pharmaceuticals

20,431

$7.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.17 (+2.20%) Today
$0.00 (0.00%) As of 3:57 PM EDT after-hours

Why Robinhood?

You can buy or sell ZYNE and other stocks, options, ETFs, and crypto commission-free!

About ZYNE

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. Read More The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.

CEO
Armando Anido
Employees
25
Headquarters
Devon, Pennsylvania
Founded
2007
Market Cap
173.64M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
602.66K
High Today
$7.78
Low Today
$7.36
Open Price
$7.51
Volume
288.75K
52 Week High
$16.47
52 Week Low
$2.75

Collections

Technology
Health
Pharmaceutical
Medical
2015 IPO
US
North America

ZYNE Earnings

-$0.91
-$0.75
-$0.60
-$0.44
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 7, Pre-Market

Popular Stocks

ADT
XLF
AZO
AOBC
SHOP
X
M
NOW
AMRH
SPYG
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ZYNE

Market Price$7.65
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ZYNE stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up